ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Larry W. Stephenson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stephenson, L. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stephenson, L. W.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2003;76:827
© 2003 The Society of Thoracic Surgeons

Invited commentary

Larry W. Stephenson, MDa

a Division of Cardiothoracic Surgery, Wayne State University School of Medicine, Harper Professional Building, Suite 2102, 3990 John R Street, Detroit, MI 48201, USA

e-mail: lstephen@dmc.org

The first 20% of the full text of this article appears below.

Since Alain Carpentier and Juan Carlos Chachques introduced clinical cardiomyoplasty in 1985, an estimated 1000 of these procedures have been done worldwide. In the phase II clinical trials conducted in the United States under the auspices of the FDA, about 80%–85% of hospital survivors showed improvement in their signs and symptoms for heart failure from several months up to a year, and sometimes much longer.

The phase III randomized clinical trial, again under the auspices . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.